Premium
Antihyperlipidemic effect of Acanthopanax senticosus (Rupr. et Maxim) Harms leaves in high‐fat‐diet fed mice
Author(s) -
Nishida Miyako,
Kondo Momoko,
Shimizu Taro,
Saito Tetsuo,
Sato Shinji,
Hirayama Masao,
Konishi Tetsuya,
Nishida Hiroshi
Publication year - 2016
Publication title -
journal of the science of food and agriculture
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.782
H-Index - 142
eISSN - 1097-0010
pISSN - 0022-5142
DOI - 10.1002/jsfa.7557
Subject(s) - lipid metabolism , adipose tissue , carnitine , obesity , metabolism , antioxidant , metabolic syndrome , chemistry , endocrinology , biology , food science , medicine , biochemistry
BACKGROUND Metabolic syndrome is a major risk factor for a variety of obesity‐related diseases. Recently, the effects of functional foods have been investigated on lipid metabolism as a means to reduce lipid content in the blood, liver and adipose tissues associated with carnitine O ‐palmitoyltransferase ( CPT ) activity. Acanthopanax senticosus (Rupr. et Maxim) Harms ( AS ) is a medicinal herb possessing a wide spectra of functions including antioxidant, anti‐inflammatory and anti‐fatigue actions. Despite much research being focused on the cortical roots of AS , little information is available regarding its leaves, which are also expected to promote human health, for example by improving abnormal lipid metabolism. Here, we explored whether AS leaves affect lipid metabolism in mice fed a high‐fat diet. RESULTS The administration of AS to BALB /c mice fed a high‐fat diet significantly decreased plasma triglycerides ( TG ). CPT activity in the liver of these mice was significantly enhanced by AS treatment. CONCLUSION These findings indicate that AS leaves have the potential to alleviate increase in plasma TG levels due to high‐fat diet intake in mice, possibly by increasing mitochondrial fatty acid β‐oxidation, especially via CPT activation. Consequently, daily intake of AS leaves could promote beneficial health effects including the prevention of metabolic syndrome. © 2015 Society of Chemical Industry